Authors' results and conclusions: Early studies have demonstrated that the Dose Verification System (DVS) is a useful device for quantifying dosages at the site of the tumour. The ability of the DVS to monitor deviations between intended dosage and dosage received at depth suggests that the device may play an important quality assurance role in the delivery of radiotherapy. The device also offers promise for gaining a better understanding of the factors responsible for fluctuations in the dosage received at depth. Despite this, evidence regarding the safety and effectiveness of the DVS is limited. Without a gold standard for measuring dosage at depth, further studies involving the implantation of multiple sensors are required to demonstrate the long-term reliability and precision of the device.

Authors' recommendations: Although evidence is limited regarding the effectiveness of the DVS, the technology may play an important role in radiotherapy quality assurance. It is therefore recommended that the technology be monitored.

Project Status: Completed

Year Published: 2006

URL for published report: Not Available

English language abstract: An English language summary is available

Publication Type: Not Assigned

Country: Australia

Organisation Name: Adelaide Health Technology Assessment

Contact Address: School of Public Health, Mail Drop 545, University of Adelaide, Adelaide SA 5005, AUSTRALIA, Tel: +61 8 8313 4617

Contact Name: ahta@adelaide.edu.au

Contact Email: ahta@adelaide.edu.au

Copyright: Adelaide Health Technology Assessment (AHTA)